Dihydropyridophthalazinone inhibitors of poly(ADP-ribose) polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency

Details for Australian Patent Application No. 2011212928 (hide)

Owner Biomarin Pharmaceutical Inc.

Inventors Chu, Daniel; Wang, Bing; Feng, Ying; Shen, Yuqiao; Post, Leonard Edwin

Agent HENRY HUGHES LTD

Pub. Number AU-A-2011212928

PCT Pub. Number WO2011/097334

Priority 61/301,174 03.02.10 US

Filing date 3 February 2011

Wipo publication date 11 August 2011

International Classifications

A01N 43/58 Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

Event Publications

9 August 2012 PCT application entered the National Phase

  PCT publication WO2011/097334 Priority application(s): WO2011/097334

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011212929-Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof

2011212927-Identification of LKB1 mutation as a predictive biomarker for sensitivity to TOR kinase inhibitors